BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28591582)

  • 1. Hepatocyte ABCA1 Deletion Impairs Liver Insulin Signaling and Lipogenesis.
    Key CC; Liu M; Kurtz CL; Chung S; Boudyguina E; Dinh TA; Bashore A; Phelan PE; Freedman BI; Osborne TF; Zhu X; Ma L; Sethupathy P; Biddinger SB; Parks JS
    Cell Rep; 2017 Jun; 19(10):2116-2129. PubMed ID: 28591582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor.
    Bashore AC; Liu M; Key CC; Boudyguina E; Wang X; Carroll CM; Sawyer JK; Mullick AE; Lee RG; Macauley SL; Parks JS
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1747-1761. PubMed ID: 31167565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ABCA1 on membrane cholesterol content, insulin-dependent Akt phosphorylation and glucose uptake in adult skeletal muscle fibers from mice.
    Sánchez-Aguilera P; Diaz-Vegas A; Campos C; Quinteros-Waltemath O; Cerda-Kohler H; Barrientos G; Contreras-Ferrat A; Llanos P
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Dec; 1863(12):1469-1477. PubMed ID: 30254016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.
    Liu M; Chung S; Shelness GS; Parks JS
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt A):1035-1043. PubMed ID: 28694219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic CREBZF couples insulin to lipogenesis by inhibiting insig activity and contributes to hepatic steatosis in diet-induced insulin-resistant mice.
    Zhang F; Hu Z; Li G; Huo S; Ma F; Cui A; Xue Y; Han Y; Gong Q; Gao J; Bian H; Meng Z; Wu H; Long G; Tan Y; Zhang Y; Lin X; Gao X; Xu A; Li Y
    Hepatology; 2018 Oct; 68(4):1361-1375. PubMed ID: 29637572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid abnormalities in alpha/beta2-syntrophin null mice are independent from ABCA1.
    Hebel T; Eisinger K; Neumeier M; Rein-Fischboeck L; Pohl R; Meier EM; Boettcher A; Froehner SC; Adams ME; Liebisch G; Krautbauer S; Buechler C
    Biochim Biophys Acta; 2015 May; 1851(5):527-36. PubMed ID: 25625330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
    Hsieh J; Koseki M; Molusky MM; Yakushiji E; Ichi I; Westerterp M; Iqbal J; Chan RB; Abramowicz S; Tascau L; Takiguchi S; Yamashita S; Welch CL; Di Paolo G; Hussain MM; Lefkowitch JH; Rader DJ; Tall AR
    Nature; 2016 Jul; 535(7611):303-7. PubMed ID: 27383786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HNF4α increases liver-specific human ATP-binding cassette transporter A1 expression and cholesterol efflux to apolipoprotein A-I in response to cholesterol depletion.
    Ohoka N; Okuhira K; Cui H; Wu W; Sato R; Naito M; Nishimaki-Mogami T
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1005-14. PubMed ID: 22282358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes.
    Lyu J; Imachi H; Fukunaga K; Sato S; Kobayashi T; Dong T; Saheki T; Matsumoto M; Iwama H; Zhang H; Murao K
    Mol Metab; 2020 Apr; 34():16-26. PubMed ID: 32180556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of ABCA1 protein expression and function in hepatic and pancreatic islet cells by miR-145.
    Kang MH; Zhang LH; Wijesekara N; de Haan W; Butland S; Bhattacharjee A; Hayden MR
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2724-32. PubMed ID: 24135019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
    Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
    J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity.
    Sachithanandan N; Fam BC; Fynch S; Dzamko N; Watt MJ; Wormald S; Honeyman J; Galic S; Proietto J; Andrikopoulos S; Hevener AL; Kay TW; Steinberg GR
    Hepatology; 2010 Nov; 52(5):1632-42. PubMed ID: 20799351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
    Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
    Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic ABCA1 expression improves β-cell function and glucose tolerance.
    de Haan W; Karasinska JM; Ruddle P; Hayden MR
    Diabetes; 2014 Dec; 63(12):4076-82. PubMed ID: 25028523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF1 suppresses cholesterol accumulation in the liver of growth hormone-deficient mice via the activation of ABCA1.
    Fukunaga K; Imachi H; Lyu J; Dong T; Sato S; Ibata T; Kobayashi T; Yoshimoto T; Yonezaki K; Matsunaga T; Murao K
    Am J Physiol Endocrinol Metab; 2018 Dec; 315(6):E1232-E1241. PubMed ID: 30130150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I and adenosine triphosphate-binding cassette transporter A1 expression alleviates lipid accumulation in hepatocytes.
    Liu W; Qin L; Yu H; Lv F; Wang Y
    J Gastroenterol Hepatol; 2014 Mar; 29(3):614-22. PubMed ID: 24219083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency in the Lipid Exporter ABCA1 Impairs Retrograde Sterol Movement and Disrupts Sterol Sensing at the Endoplasmic Reticulum.
    Yamauchi Y; Iwamoto N; Rogers MA; Abe-Dohmae S; Fujimoto T; Chang CC; Ishigami M; Kishimoto T; Kobayashi T; Ueda K; Furukawa K; Chang TY; Yokoyama S
    J Biol Chem; 2015 Sep; 290(39):23464-77. PubMed ID: 26198636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.